Infection prevention & Control Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Infection prevention & control market
Infection prevention & Control Market: By Infections (Microbial & Others); By Antimicrobial Drugs (Antibacterial & Others); By Accessories & Equipment (Disinfectants & Others); By End User (Equipment & Drug Usage) & By Geography - Forecast (2018-2023)
Report Code : HCR 0022
Updated Date: 28 October, 2018  
10

Copies sold

    Client Rating

1. Infection prevention & Control Market - Overview
1.1. Definitions and Scope
2. Infection prevention & Control Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Infection prevention & Control Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Infection prevention & Control Market – Startup companies Scenario
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Infection prevention & Control Market – Industry Market Entry Scenario
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Infection prevention & Control Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Infection prevention & Control Market -Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. Infection prevention & Control Market – By Infections (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. Microbial infections
8.3.1.1. Bacterial infection
8.3.1.1.1. Clostridium Difficile
8.3.1.1.2. Mycobacterium tuberculosis
8.3.1.1.3. E. Coil
8.3.1.1.4. Helicobacter pylori
8.3.1.1.5. Salmonella
8.3.1.1.6. Salmonella
8.3.1.2. Viral infection
8.3.1.2.1. Ebola Virus
8.3.1.2.2. Herpes Simplex Virus
8.3.1.2.3. Human Immunodeficiency Virus (HIV)
8.3.1.2.4. Yellow Fever
8.3.1.2.5. Dengue Viruses
8.3.1.2.6. Junin Virus
8.3.1.2.7. KFD (Kyasanur Forest Virus)
8.3.1.2.8. Machupo Virus
8.3.1.2.9. Others
8.3.1.3. Fungal Infection
8.3.1.3.1. Cryptococcus Gatti
8.3.1.3.2. Aspergillis
8.3.1.3.3. Pneumocystis Pneumonia
8.3.1.3.4. Dermatophytes
8.3.1.3.5. Gungal Keratitis
8.3.1.3.6. Exserohilum
8.3.1.3.7. Cladosporium
8.3.1.3.8. Other
8.3.2. Healthcare Associated Infections
8.3.2.1. Hospital Acquired Infection
8.3.2.1.1. Central line associated bloodstream infection (CLABSI)
8.3.2.1.2. Catheter associated Urinary Tract infection
8.3.2.1.3. Surgical site infection 
8.3.2.1.4. Ventilator associated Pneumonia (VAP) infection
8.3.2.2. Community acquired infection
8.3.2.2.1. Methicillin resistant Staphylococcus aureus (MRSA) infection
8.3.2.2.2. Community acquired pneumonia
9. Infection prevention & Control Market – By Antimicrobial drugs (Market Size -$Million / $Billion)
9.1. Anti-bacterial Drug
9.2. Anti-Viral Drug
9.3. Anti-fungal Drug
9.4. Vaccine
10. Infection prevention & Control Market – By Accessories and Equipment (Market Size -$Million / $Billion)
10.1. Personal Protective Equipment
10.1.1. Gloves
10.1.2. Surgical Masks & Respirators
10.1.3. Surgical Drapes & Gown
10.1.4. Surgical Foot covers 
10.1.5. Medical safety Glasses
10.1.6. Others
10.2. Disinfectants
10.2.1. Hand sanitizers
10.2.2. Disinfectants wipes
10.2.3. Surface Disinfectants
10.2.4. Instrument Disinfectants
10.2.5. Environmental Disinfectants
10.2.6. Others
10.3. Sterilization
10.3.1. Medical Device Sterilization Equipment
10.3.1.1. Wet/Stream Sterilization (Autoclave)
10.3.1.1.1. Vertical Autoclave
10.3.1.1.2. Horizontal Autoclave
10.3.1.1.3. Portable Autoclave
10.3.1.2. Dry Heat Sterilization
10.3.1.3. Low Temperature Sterilization
10.3.1.3.1. In-House Steam Sterilization
10.3.1.3.2. Ethylene Oxide (EO) Sterilization
10.3.1.3.3. Gamma and eBeam Sterilization
11. Infection prevention & Control – By End Use Industry(Market Size -$Million / $Billion)
11.1. Segment type Size and Market Share Analysis 
11.2. Application Revenue and Trends by type of Application
11.3. Application Segment Analysis by Type
11.3.1. End Users: By Equipment Usage
11.3.1.1. Hospitals & Clinics
11.3.1.2. Medical Laboratories
11.3.1.3. Manufacturing Units
11.3.1.3.1. Pharmaceuticals
11.3.1.3.2. Medical Devices
11.3.1.3.3. Food & Beverages 
11.3.2. End users: By Drug Usage
11.3.2.1. Individuals & Patients
11.3.2.2. Nursing & Senior care Centers
12. Infection prevention & Control - By Geography (Market Size -$Million / $Billion)
12.1. Infection prevention & Control Market - North America Segment Research
12.2. North America Market Research (Million / $Billion)
12.2.1. Segment type Size and Market Size Analysis 
12.2.2. Revenue and Trends
12.2.3. Application Revenue and Trends by type of Application
12.2.4. Company Revenue and Product Analysis
12.2.5. North America Product type and Application Market Size
12.2.5.1. U.S.
12.2.5.2. Canada 
12.2.5.3. Mexico 
12.2.5.4. Rest of North America
12.3. Infection prevention & Control - South America Segment Research
12.4. South America Market Research (Market Size -$Million / $Billion)
12.4.1. Segment type Size and Market Size Analysis 
12.4.2. Revenue and Trends
12.4.3. Application Revenue and Trends by type of Application
12.4.4. Company Revenue and Product Analysis
12.4.5. South America Product type and Application Market Size
12.4.5.1. Brazil  
12.4.5.2. Venezuela
12.4.5.3. Argentina
12.4.5.4. Ecuador
12.4.5.5. Peru
12.4.5.6. Colombia 
12.4.5.7. Costa Rica
12.4.5.8. Rest of South America
12.5. Infection prevention & Control - Europe Segment Research
12.6. Europe Market Research (Market Size -$Million / $Billion)
12.6.1. Segment type Size and Market Size Analysis 
12.6.2. Revenue and Trends
12.6.3. Application Revenue and Trends by type of Application
12.6.4. Company Revenue and Product Analysis
12.6.5. Europe Segment Product type and Application Market Size
12.6.5.1. U.K  
12.6.5.2. Germany 
12.6.5.3. Italy 
12.6.5.4. France
12.6.5.5. Netherlands
12.6.5.6. Belgium
12.6.5.7. Spain
12.6.5.8. Denmark
12.6.5.9. Rest of Europe
12.7. Infection prevention & Control – APAC Segment Research
12.8. APAC Market Research (Market Size -$Million / $Billion)
12.8.1. Segment type Size and Market Size Analysis 
12.8.2. Revenue and Trends
12.8.3. Application Revenue and Trends by type of Application
12.8.4. Company Revenue and Product Analysis
12.8.5. APAC Segment – Product type and Application Market Size
12.8.5.1. China 
12.8.5.2. Australia
12.8.5.3. Japan 
12.8.5.4. South Korea
12.8.5.5. India
12.8.5.6. Taiwan
12.8.5.7. Malaysia
13. Infection prevention & Control Market - Entropy
13.1. New product launches
13.2. M&A's, collaborations, JVs and partnerships
14. Infection prevention & Control Market – Industry / Segment Competition landscape
14.1. Market Share Analysis
14.1.1. Market Share by Country- Top companies
14.1.2. Market Share by Region- Top 10 companies
14.1.3. Market Share by type of Application – Top 10 companies
14.1.4. Market Share by type of Product / Product category- Top 10 companies
14.1.5. Market Share at global level- Top 10 companies
14.1.6. Best Practises for companies
15. Infection prevention & Control Market – Key Company List by Country
16. Infection prevention & Control Market Company Analysis
16.1. Market Share, Company Revenue, Products, M&A, Developments
16.2. ABBOTT LABORATORIES (ABBOTT DIACNOSTICS)
16.3. ALERE
16.4. ANSELL LIMITED
16.5. ASTRAZENECEA
16.6. BARD (CR) INCORPORATED
16.7. BECTON, DICKINSON AND COMPANY
16.8. BELIMED
16.9. CANTEL
16.10. Company 9
16.11. Company 10 and More
"*Financials would be provided on a best efforts basis for private companies"
17. Infection prevention & Control Market -Appendix
17.1. Abbreviations
17.2. Sources
18. Infection prevention & Control Market -Methodology
18.1. Research Methodology
18.1.1. Company Expert Interviews
18.1.2. Industry Databases
18.1.3. Associations
18.1.4. Company News
18.1.5. Company Annual Reports
18.1.6. Application Trends
18.1.7. New Products and Product database
18.1.8. Company Transcripts
18.1.9. R&D Trends
18.1.10. Key Opinion Leaders Interviews
18.1.11. Supply and Demand Trends
Please select Licence
Single User Licence:
US $5250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll